Zamzami Tarik Y Yamani
Department of Obstetrics and Gynecology, King Abdulaziz University Hospital, P.O. Box 80215, Jeddah, 21589, Saudi Arabia.
Arch Gynecol Obstet. 2005 Dec;273(3):176-9. doi: 10.1007/s00404-005-0066-2. Epub 2005 Sep 14.
To compare the outcome of labor in grand multiparous women (para 6 or more) who had induction of labor with vaginal prostaglandin E2 with grand multiparous women in spontaneous labor.
A retrospective case-control study was performed, 202 grand multiparous women were induced labor with vaginal prostaglandin E2 and compared with outcomes with grand multiparous women who entered in spontaneous labor and delivered during the same study period and served as control group.
There were no statistically significant differences in the duration of labor, fetal birth weight, use of oxytocin augmentation, and Apgar scores in the two groups. Fourteen women (6.9%) in the induction group delivered by cesarean section compared to six woman (3.0%) in the control group. This was a statistically significant difference (P = 0.01). In the induction group, the mean duration of the hospital stay was longer (P = 0.003) and there was one neonatal fetal death and one uterus rupture.
Induction of labor with vaginal prostaglandin E2 in grand multiparous women is still relatively safe.
比较接受阴道前列腺素E2引产的经产妇(产次为6次或更多)与自然分娩的经产妇的分娩结局。
进行了一项回顾性病例对照研究,202名经产妇接受阴道前列腺素E2引产,并与在同一研究期间自然分娩的经产妇的结局进行比较,后者作为对照组。
两组在产程、胎儿出生体重、催产素加强使用情况及阿氏评分方面无统计学显著差异。引产组有14名妇女(6.9%)行剖宫产,而对照组有6名妇女(3.0%)行剖宫产。这是一个统计学显著差异(P = 0.01)。在引产组,平均住院时间更长(P = 0.003),且有1例新生儿死亡和1例子宫破裂。
经产妇使用阴道前列腺素E2引产仍然相对安全。